Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

[Reversed changes of the 15-lipoxygenase product lipoxin A₄ and the 5-lipoxygenase product leukotriene C₄ in children with asthma].

Yin PL, Wu SH, Yao WJ, Wu HM, Jiang HM, Su HP, Xu D, Ye XL.

Zhonghua Jie He He Hu Xi Za Zhi. 2010 Jul;33(7):530-3. Chinese.

PMID:
20979801
2.

Reversed changes of lipoxin A4 and leukotrienes in children with asthma in different severity degree.

Wu SH, Yin PL, Zhang YM, Tao HX.

Pediatr Pulmonol. 2010 Apr;45(4):333-40. doi: 10.1002/ppul.21186.

PMID:
20232472
3.

Inverse temporal changes of lipoxin A4 and leukotrienes in children with Henoch-Schönlein purpura.

Wu SH, Liao PY, Yin PL, Zhang YM, Dong L.

Prostaglandins Leukot Essent Fatty Acids. 2009 Apr;80(4):177-83. doi: 10.1016/j.plefa.2009.01.008. Epub 2009 Mar 4.

PMID:
19264468
4.

Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis.

Wu SH, Liao PY, Yin PL, Zhang YM, Dong L.

Am J Pathol. 2009 Jan;174(1):115-22. doi: 10.2353/ajpath.2009.080671. Epub 2008 Dec 18.

5.

Eoxins: a new inflammatory pathway in childhood asthma.

Sachs-Olsen C, Sanak M, Lang AM, Gielicz A, Mowinckel P, Lødrup Carlsen KC, Carlsen KH, Szczeklik A.

J Allergy Clin Immunol. 2010 Oct;126(4):859-867.e9. doi: 10.1016/j.jaci.2010.07.015.

PMID:
20920774
6.

Lipoxin synthesis by arachidonate 5-lipoxygenase purified from porcine leukocytes.

Ueda N, Yamamoto S, Fitzsimmons BJ, Rokach J.

Biochem Biophys Res Commun. 1987 Apr 29;144(2):996-1002.

PMID:
3579953
7.

Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma.

Planagumà A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E, Bleecker ER, Curran-Everett D, Erzurum SC, Calhoun WJ, Castro M, Chung KF, Gaston B, Jarjour NN, Busse WW, Wenzel SE, Levy BD.

Am J Respir Crit Care Med. 2008 Sep 15;178(6):574-82. doi: 10.1164/rccm.200801-061OC. Epub 2008 Jun 26.

8.

Conformational analysis of lipoxin A, lipoxin B and their trans-isomers.

Brasseur R, Deleers M, Ruysschaert JM, Samuelsson B, Serhan CN.

Biochim Biophys Acta. 1988 May 22;960(2):245-52.

PMID:
3365446
9.

ALOX5 promoter genotype, asthma severity and LTC production by eosinophils.

Kalayci O, Birben E, Sackesen C, Keskin O, Tahan F, Wechsler ME, Civelek E, Soyer OU, Adalioglu G, Tuncer A, Israel E, Lilly C.

Allergy. 2006 Jan;61(1):97-103.

10.

The role of lipoxin A4 in exercise-induced bronchoconstriction in asthma.

Tahan F, Saraymen R, Gumus H.

J Asthma. 2008 Mar;45(2):161-4. doi: 10.1080/02770900701847068.

PMID:
18350409
11.

Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis.

Pérez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert C.

J Allergy Clin Immunol. 2005 Jun;115(6):1189-96.

PMID:
15940133
12.

Leukotriene B4 and C4 generation by human leukocytes after ex vivo stimulation with Ca-ionophore and opsonized zymosan in children with atopic asthma.

Kristjánsson S, Shimizu T, Wennergren G, Strannegård IL, Strandvik B.

Pediatr Allergy Immunol. 1995 Aug;6(3):155-60.

PMID:
8750311
13.

Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound.

Vachier I, Bonnans C, Chavis C, Farce M, Godard P, Bousquet J, Chanez P.

J Allergy Clin Immunol. 2005 Jan;115(1):55-60.

PMID:
15637547
14.

Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein mRNAs in the peripheral blood leukocytes of asthmatics.

Koshino T, Takano S, Houjo T, Sano Y, Kudo K, Kihara H, Kitani S, Takaishi T, Hirai K, Ito K, Morita Y.

Biochem Biophys Res Commun. 1998 Jun 18;247(2):510-3.

PMID:
9642160
15.

Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.

Tateson JE, Randall RW, Reynolds CH, Jackson WP, Bhattacherjee P, Salmon JA, Garland LG.

Br J Pharmacol. 1988 Jun;94(2):528-39.

16.

Comparison of 5- and 15-lipoxygenase activities in blood and alveolar leukocyte preparations from normal subjects and patients with eosinophilia.

Laviolette M, Picard S, Braquet P, Borgeat P.

Prostaglandins Leukot Med. 1986 Aug;23(2-3):191-9.

PMID:
3020586
17.

Lipoxin synthesis by arachidonate 12-lipoxygenase purified from porcine leukocytes.

Ueda N, Yokoyama C, Yamamoto S, Fitzsimmons BJ, Rokach J, Oates JA, Brash AR.

Biochem Biophys Res Commun. 1987 Dec 31;149(3):1063-9.

PMID:
3122743
18.

Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators.

Kowal-Bielecka O, Kowal K, Distler O, Rojewska J, Bodzenta-Lukaszyk A, Michel BA, Gay RE, Gay S, Sierakowski S.

Arthritis Rheum. 2005 Dec;52(12):3783-91.

19.

The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.

Yüksel B, Aydemir C, Ustündag G, Eldeş N, Kutsal E, Can M, Demirtaş S, Tomaç N.

Turk J Pediatr. 2009 Sep-Oct;51(5):460-5.

PMID:
20112601
20.

Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma.

Volovitz B, Tabachnik E, Nussinovitch M, Shtaif B, Blau H, Gil-Ad I, Weizman A, Varsano I.

J Allergy Clin Immunol. 1999 Dec;104(6):1162-7.

PMID:
10588996

Supplemental Content

Support Center